| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.80▼ | 1.82▼ | 1.83▼ | 1.88▼ | 1.92▼ |
| MA10 | 1.80▼ | 1.84▼ | 1.84▼ | 1.96▼ | 2.01▼ |
| MA20 | 1.82▼ | 1.84▼ | 1.85▼ | 2.00▼ | 1.89▼ |
| MA50 | 1.85▼ | 1.88▼ | 1.92▼ | 2.08▼ | 1.70▲ |
| MA100 | 1.83▼ | 1.93▼ | 2.00▼ | 1.84▼ | N/A |
| MA200 | 1.87▼ | 2.02▼ | 1.96▼ | 1.60▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.004▼ | 0.000▲ | -0.023▼ | 0.000▲ |
| RSI | 37.537▼ | 38.944▼ | 39.763▼ | 41.017▼ | 45.592▼ |
| STOCH | 20.417 | 15.205▼ | 42.716 | 18.293▼ | 36.013 |
| WILL %R | -100.000▼ | -100.000▼ | -74.194 | -90.909▼ | -74.257 |
| CCI | -62.063 | -123.563▼ | -53.745 | -131.941▼ | -99.168 |
|
Thursday, November 06, 2025 04:01 AM
WELLESLEY HILLS, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases, ...
|
|
Monday, November 03, 2025 04:59 AM
WELLESLEY HILLS, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that members of ...
|
|
Friday, October 31, 2025 02:42 AM
Climb Bio Inc. (NASDAQ:CLYM) is one of the best stocks under $3 to invest in. On October 16, William Blair analyst Matt Phipps initiated coverage of Climb Bio with an Outperform rating but no price ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/11/25 | 1.89 | 1.92 | 1.79 | 1.80 | 315,500 |
| 07/11/25 | 1.89 | 1.89 | 1.75 | 1.83 | 511,528 |
| 06/11/25 | 1.87 | 1.975 | 1.86 | 1.95 | 468,137 |
| 05/11/25 | 1.90 | 1.98 | 1.86 | 1.92 | 348,603 |
| 04/11/25 | 1.94 | 1.97 | 1.85 | 1.88 | 482,892 |
| 03/11/25 | 2.05 | 2.10 | 1.93 | 2.00 | 623,900 |
| 31/10/25 | 2.00 | 2.07 | 1.96 | 2.05 | 383,900 |
| 30/10/25 | 2.07 | 2.12 | 1.965 | 1.99 | 731,100 |
| 29/10/25 | 2.05 | 2.18 | 2.00 | 2.08 | 837,600 |
| 28/10/25 | 2.12 | 2.12 | 1.95 | 2.08 | 493,273 |
|
|
||||
|
|
||||
|
|